Come to think of it not-at-any-price may well be Pande's handle. Both are rather familiar with GSAT.
Pande was utterly obsessed with dilution and so is not-at-any-price. Pande articles now can not be accessed on SA anymore. Only available to PRO subscribers. Just thinking.
Narcissists believe they know it all and know it best. They continually have the urge to let others know so. Another trait it to put other people down believing that it makes them look better and smarter. However, it always tells more about the narcissist then about his target.
You appeared suddenly on April 11 and ever since have been a very prolific poster. In a weak moment you said something about yourself on the TYLO subject on April 11 that may explain your cynical posts.
Excellent. Good luck with yesterday's trade of about 36,000 shares, give or take a few hundred. You have far more money than I. My largest purchases ever was for about $15,000 and they were for long term. But of course, everything is relative. I would not have comfort purchasing blocks of $100k, unless I had such deep pockets. If someone has $1,000, and uses all of it to make an investment, that is a major commitment.
Jay Monroe directly, and indirectly through Thermo, is the largest shareholder (well over 50 %) of GSAT. He risked substantial sums of Thermo's and his own money to carve out a place for GSAT in this business believing they had the technology, the spectra, to become a very successful operation.
Look at Yahoo's major folders and you see a listing of all institutions and mutual funds to the tune of 12 % of the outstanding shares. You really believe they all are stupid and do not understand business? The reality is, everyone believes in what GSAT can and likely will become, and all these institutions, mutual funds and retail investors are along for the ride. The cumulative effect of these investments have raised the PPS which in turn has lowered the cost of capital to GSAT, through attractive conversions of debt into stock and through potential offerings at ever increasing PPSs.
Don't behave like a nincompoop. Obviously you don't watch CNBC. They rarely give their guests a chance to cover all the bases, no pun intended.
I am not part of the old guard but read your message.
Tell them to be proactive and ask questions, lots of them. With mutation testing becoming more prevalent here is a good site:
The most common mutation is BRAF and there are promising drugs out there.
My wife has lung cancer and has the BRAF mutation which rare in LC. There is no drug for BRAF in LC yet but there is a possible crossover from melanoma. I did discuss electroporation and ONCS with my wife's oncologist. There does not seem a lot of knowledge about it in many clinics as yet but that can change soon. Everyone does follow the ASCO.
Best wishes to your brother-in-law and sister.
Bid and ask prices are in constant flux. Between the time you type your limit order and sent it out the market could have changed already. So, you either don't get filled or get filled at your limit or get a better deal. I use mainly Schwab and I always get filled at the limit order or better. With another broker I get filled at the limit order even if the market allowed a more favorable fill. The latter gives that broker extra margin over and above the commission. I feel safe with Schwab to place order at market, with the other I don't because invariably I get a worse deal than the market allowed. This at least is my experience.
Despite the negative impact of this type of dilution, without it the company would likely be worth zilch by now. The dilution has helped to get the company back on track and now the stock is worth $2.50+ with likely much higher valuation in its future.
If I need to pick between no dilution and losing my money or dilution and making a bundle, I'll take the latter over the former 100 % of the time.
I know you did not. What I am implying is that he will go as fast as the process will allow him. Once he has all the information to decide it will be decided. He will not dither.
Not familiar with what standard comment period applies to issues before he FCC. It may depend on the issue. Given the potential monetary value at stake they will want to make sure it is done right and beyond reproach is as much one can expect a government entity to do so.
To-date at no time has Wheeler given an impression of being a bureaucratic procrastinator. Numerous times he has laid out what he wants accomplished and I believe he will go about this in as expeditious a manner as circumstances and FCC rules and regulations will allow him. He is a doer and wants to make sure he reaches his objectives without unnecessary delays. Just MHO.
It will be a dilution. The differential though may have been mostly accounted for at the end of the last quarter. That said, it reduces the debt further easing the cost of financing it.
Can relate to the sentiments you expressed. The major catalyst will be the approval. Chances are good that it will happen and then everything else will fall in place.
I assume the broker is ultimately responsible for any failure by the short seller so therefore short positions can be transferred from OTC to NYSE because they are not on the hook.
Someone help out here
It may well be that this was the bottom.
Interesting question on how short positions are treated when transitioning from OTC to NYSE. Don't know the answer but surely like to know.
Actually Schwab is pretty good at catching erroneous buy orders. At worst you would have bought at market. Some of the other brokers are not that honest.
GSAT has what Google wants and Google has what GSAT wants ($$$$). Could become a very beneficial mutual relationship.
If the MMs intent was to shake lose weak hands then there is just so low they can go. Once the price drops to 50 cents or less few are going to sell. Then it is pretty much the cost of an option without expiration date.